6th World Pharmacists & Clinical Pharmacy Annual Congress

From Verify.Wiki
Jump to: navigation, search
QuickUpload1132 20170612060837.jpg
6th World Pharmacists & Clinical Pharmacy Annual Congress
Date May 22-23, 2017
Place Chicago, Illinois, USA

ConferenceSeries Ltd invites all the participants across the globe to attend “6th World Pharmacists & Clinical Pharmacy Annual Congress”[1] during May 22-23, 2017 Chicago, Illinois, USA which includes prompt keynote presentations, oral talks, poster presentations and exhibitions. WPCP 2017 aims to provide a forum for international researchers from various areas of pharmacy, pharmaceutical sciences, clinical pharmacy by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of pharmacy meeting.

Conference Highlights

  • Clinical Pharmacy & Its Key Role in Treatment
  • Hospital Pharmacy
  • Pharma Research & Development
  • Industrial Pharmacy
  • Pharmacist in Health Care System
  • General Clinical Pharmacology
  • Pharmacy Practice
  • Clinical Pharmacy Activities and Prescriptions
  • Community Pharmacy
  • Clinical Pharmacy and Drug Reactions
  • Nuclear Pharmacy
  • Clinical Pharmacy and Therapeutics
  • Ambulatory Care Pharmacy
  • Clinical Drug Development and Therapeutics
  • Home Health Care Pharmacy
  • Managed Care Pharmacy
  • Pharmacy Technicians & Assistants
  • Current Advances in Pharmacy Practice
  • Entrepreneurs Investment Meet

Importance and Scope

Pharmacy is a dynamic profession that is continually evolving to better contribute to patient care, in the face of the escalating complexity of health technology and healthcare services. Pharmacists are cited as being “medicine experts”, yet current practice frequently demands they act as distributors of medicines who operate as the final step of a patient’s journey, as opposed to being an essential component of the medication-use system. They are often the first port of call for people to get advice on health in general, as well as specific clinical conditions. Pharmacists have a significant role in assessing medication management in patients, and in referring patients to physician’s clinical medication management, including reviewing and monitoring of medication regimens. Pharmacists have long been providing health services in every region of Australia, and while they remain mostly outside the glare of the limelight, the profession remains one amongst the foremost revered within the community. With the development of specific and potent synthetic drugs, the emphasis of the pharmacist’s responsibility has moved substantially towards the utilization of scientific knowledge in the proper use of modern medicines and the protection of the public against dangers that are inherent in their use. Pharmacists are employed in regulatory control and drug management, community pharmacy, hospital pharmacy, the pharmaceutical industry, academic activities, training of other health workers, and research. In all these fields, their intention is to ensure optimum drug therapy, both by contributing to the preparation, supply and control of medicines and associated products, and by providing information and advice to those who prescribe or use pharmaceutical products ultimately improving the quality of a patient’s life. They strive to be a source of advice on medication for both health-care professionals as well as patients. They also are dedicated to providing individualized services to patients.

The market environment in which Pharmaceutical and Life Sciences companies operate is progressively challenging, being driven by a more and more demanding healthcare agenda leading to a new marketing and sales system The global need for innovative, cost effective medicines continues to rise whilst regulators, payers, health care providers and patients are demanding greater value for money, proven effectiveness of products, more transparency and access to information.The pressure to reduce costs and prove value in life sciences is intense. Increasingly, life sciences companies are expected to justify the cost of their products using improved targeting, comparative effectiveness (CE) measures, and real-world evidence (RWE) in addition to hard clinical endpoints. Adding to the pressure, the costs of bringing a new medicine to market have never been higher – and they continue to rise while drug price cost-containment measures or value-based pricing and reimbursement models continue to rise. Increasingly engaged and empowered health care consumers are demanding services and solutions that are coordinated, convenient, customized, and accessible. This trend is being driven by factors including patients’ ability to change their own outcomes based on behavior; financial scrutiny due to cost-sharing models that push more costs onto the patient; the industry’s shift towards evaluating outcomes to determine value delivered to the patient; and the availability of technology solutions providing patients with more information and ways to communicate (i.e. social media and networks); and the ability to play an active role in managing their well-being. The increase in data and information access, mobile applications, and personal health devices is accelerating the pace of consumer engagement in health care. Large pharmaceutical companies focused on traditional markets have lagged in responding to the industry’s changing focus towards holistic patient management.


  1. http://annualmeeting.conferenceseries.com/pharmacists/

Verification history